🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Part A: The primary objective is to evaluate the safety and tolerability of...
Status
Completed
Location
Biokinetic Europ Ltd
Start Date
2015-05
Trial ID
NCT02459262
Treatments Being Tested
The objective of this extension study is the initial assessment of safety a...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-29
Trial ID
NCT02690181
Treatments Being Tested
Collection of serum from women not living with HIV, who received the GBS6 v...
Status
Recruiting
Location
MUJHU Care Ltd, Kampala
Start Date
2026-03-27
Trial ID
NCT07562061
Treatments Being Tested
Vaccines routinely used are extremely safe; however, severe adverse events ...
Status
Recruiting
Location
British Columbia Children's Hospital Research Institute
Start Date
2022-06-24
Trial ID
NCT05212792
Treatments Being Tested
Evaluate the safety and immunogenicity of the trivalent group B streptococc...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-18
Trial ID
NCT02046148
Treatments Being Tested
This study looks at the body's immune responses to a GBS vaccine 2 years af...
Status
Completed
Location
Institute for Pharmacokinetic and Analytical Studies
Start Date
2010-01
Trial ID
NCT01052935
Treatments Being Tested
The purpose of the present study is to assess and compare in healthy non-pr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-20
Trial ID
NCT02270944
Treatments Being Tested
We are conducting a large, record-based study to assess the risk of Guillai...
Status
Completed
Location
HealthCore, Inc.
Start Date
2005-03
Trial ID
NCT00575653
The goal of this follow-up study is to investigate the persistence of the i...
Status
Terminated
Location
Simbec-Orion Clinical Pharmacology
Start Date
2024-01-18
Trial ID
NCT06280157
Treatments Being Tested
This study will evaluate the safety and immunogenicity of a Group B Strepto...
Status
Completed
Location
Chris Hani Baragwanath Hospital
Start Date
2010-10
Trial ID
NCT01193920